Announcements Trials
Browse Landscape

Phase

Phase 2 78Phase 3 27Phase NA 7Phase 4 6Phase 2/3 5Phase 1/2 5Phase 1 5Phase EARLY_PHASE1 3

Status

Recruiting 8Unknown 5Completed 5Terminated 3Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 4Tumor-Agnostic 1

Conditions

Nonsquamous Non-small Cell Lung Cancer 1Neoplasms 1NSCLC 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Pemetrexed × Clear all
NCT03380468 2023-07-20

ECTOP-1004

Fudan University

Phase 2/3 Unknown
300 enrolled
Thoracic

Adenocarcinoma of Lung, Lung Neoplasms

NCT05209256 2022-01-26

Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC

The First Affiliated Hospital of Henan University of Science and Technology

Phase 2/3 Unknown
90 enrolled
Thoracic

NSCLC

NCT04750083 2021-02-11

HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer

Taizhou Hanzhong biomedical co. LTD

Phase 2/3 Unknown
700 enrolled
Thoracic

Nonsquamous Non-small Cell Lung Cancer

NCT02777788 2017-10-10

TCM

Shanghai University of Traditional Chinese Medicine

Phase 2/3 Unknown
120 enrolled
Tumor-Agnostic

Neoplasms

NCT01481259 2012-07-03

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

People's Hospital of Guangxi Zhuang Autonomous Region

Phase 2/3 Unknown
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡